BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 15, 2025
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for July 15, 2021

July 15, 2021
Biopharmas raising money in public or private financings, including: Absci, Adial, Adlai, Biocure, Biovaxys, Calliditas, Grit, Immunic, IMV, Palo Santo, Purnovate, Stemson and Wugen.
Read More
Puzzle pieces missing from $100 bill

Med-tech financings lose speed in Q2, despite solid IPOs, VC rounds

July 14, 2021
By Karen Carey
The number of med-tech IPOs completed in the first half of 2021 is nearly as many as last year’s full year, and amounts raised through venture capital rounds in just six months are only about $100 million shy of record funds raised in all of 2020.
Read More

Financings for July 14, 2021

July 14, 2021
Med-tech firms raising money in public or private financings, including: Castor, Dopavision, Entos, Intuitap, Kontrol, Lemaitre, Mammoth, Spire.
Read More
IPO, coins, financial chart
Newco news

Poolbeg Pharma takes ‘AIM’ at flu with $35M IPO in London

July 14, 2021
By Cormac Sheridan
DUBLIN – Poolbeg Pharma plc raised £25 million (US$35 million) in an IPO on London’s Alternative Investment Market (AIM) to pursue development of antiviral drugs. The company priced the offering at 10 pence per share, which implies a valuation of £50 million. Shares are due to commence trading on Monday, July 19.
Read More

Financings for July 14, 2021

July 14, 2021
Biopharmas raising money in public or private financings, including: Allena, Axonis, Celldex, Entos, Formue, Imara, Inmune, Jatt, Karolinska, Kriya, Ocean, Ribon, Saniona and Transcode.
Read More
HKEX building

Keymed raises $378M in Hong Kong debut

July 13, 2021
By Gina Lee
Keymed Biosciences Inc. debuted on the Hong Kong Stock Exchange (HKSE) on July 8, raising HK$2.94 billion (US$378.48 million) in the process. The company will use the funds raised for the R&D and commercialization of key pipeline candidates.
Read More

Amaroq Therapeutics launches with NZ$14M seed funding to develop long non-coding RNA therapies

July 13, 2021
By Tamra Sami
PERTH, Australia – Amaroq Therapeutics Ltd., a spinout out of the University of Otago in Dunedin, New Zealand, has launched after securing NZ$14 million (US$9.7 million) in seed funding to develop long non-coding RNAs to treat breast, colorectal and liver cancer.
Read More
Hong Kong stock market illustration

Brii Biosciences debuts in Hong Kong with $319M IPO, shares close 3.15% higher

July 13, 2021
By Doris Yu
Brii Biosciences Ltd. raised HK$2.482 billion (US$319 million) in its IPO in Hong Kong and will use the proceeds to support the development of its key assets, which includes programs for hepatitis B virus (HBV), HIV and drug-resistant infections.
Read More
Q-biotics-Fontainea-flower 7-13
Newco news

Qbiotics closes AU$85M capital raise to progress plant-derived oncology, wound healing assets

July 13, 2021
By Tamra Sami

PERTH, Australia – Following a AU$85 million (US$64.41 million) capital raise, Qbiotics Group Ltd. is progressing its oncology clinical program for lead candidate tigilanol tiglate, a natural product that is isolated from the seed of the Australian rainforest native shrub Fontainea.


Read More

Financings for July 13, 2021

July 13, 2021
Biopharmas in Asia-Pacific raising money in public or private financings, including: Eisbach, Hutchmed.
Read More
Previous 1 2 … 371 372 373 374 375 376 377 378 379 … 578 579 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 14, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 14, 2025.
  • Illustration of liver with DNA double helixes

    ASGCT 2025: Gene and cell therapies transform metabolic diseases

    BioWorld Science
    Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
  • Noah Medical

    ​FDA floods Noah Medical with multi-deviation warning letter

    BioWorld MedTech
    Companies new to the world of U.S. FDA regulation are often unaware of how detailed the agency’s inspections are, which might be the case with the...
  • Scorpion Therapeutics patents p53 Y220 mutant activators

    BioWorld Science
    Work at Scorpion Therapeutics Inc. has led to the identification of cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing